• Alien Nathan Edward@lemm.ee
      link
      fedilink
      arrow-up
      54
      ·
      1 year ago

      The secondary patent particularly irked some advocates because the drug’s development was largely underwritten by public funds, according to a 2020 analysis. That study found public sector funds contributed $455 million to $747 million to getting bedaquiline to market, compared to $90 million to $240 million from J&J.

      We pay for the development of the drug, they get the patent, then we pay for the drug. Socialize cost, privatize profits.

      • yesdogishere@kbin.social
        link
        fedilink
        arrow-up
        1
        arrow-down
        4
        ·
        1 year ago

        most of the hype about danger from talcum powder is quite fake. the link between cancer and the powder is hugely tenuous and the researchers are quite shameful. Poor J&J are being victimised when there are millions sufferring from the absence of their valuable and safe talcum powder,